liveonearth (liveonearth) wrote,

New Tx for Metastatic Melanoma: PLX4032

melanoma prognosis: good if caught before mets, poor after (9 mo survival)
9,000 pts/yr die of it in US
drugs currently approved to tx metastatic melanoma: interleukin-2 and dacarbazine
benefit less than 20% of pts

experimental anticancer drug: PLX4032
developed by Plexxikon Inc. of Berkeley
licensed to Roche Pharmaceuticals
may help with other cancers that share this mutation

PLX4032 targets BRAF gene that stims tumor growth
about 50% of melanoma pts have mutated gene that won't shut off, BRAF protein produced constantly
drug benefits 80%+ of patients with metastatic melanoma, tho only for about 8 mo no tumor progression
tumors become resistant to the drug

small Phase II clinical trial (n=32 with BRAF mutation)-->larger Phase III trial next
reported in NEJM
drug given oral bid, less SEs than chemo
in 26 pts tumor shrank 30%+, 2 other pts had lesser tumor size reductions, 2 pts had tumors disappear

to enroll in trials at UCLA call (888) 798-0719.

Tags: cancer, medicine, melanoma, pharmacology, skin

  • Wolverine Watchmen: Wannabe X-men vs the Feds

    I've been interested in human xenophobia (which I think is instinctive) and race and class warfare since I become politically aware some time in…

  • A Request of Runners in Pandemic Times

    Living in an urban area I, like many, exercise in the park. I was doing so before the pandemic started and I have continued. My local park is big…

  • I, too, sing America

    I, too, sing America. I am the darker brother. They send me to eat in the kitchen When company comes, But I laugh, And eat well, And grow strong.…

  • Post a new comment


    Comments allowed for friends only

    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded